← Back to All Filings

Outset Medical (OM) Officer Files to Sell Shares for Tax Obligations

Low SignificanceNovember 17, 2025 at 7:02:38 PM EST

Outset Medical, Inc.

$OM144CIK: 0001484612

Subscribe to track OM

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Outset Medical (OM) Officer Files to Sell Shares for Tax Obligations

Company: Outset Medical, Inc. (OM) Form: 144 | Filed: 2025-11-17 Significance: Low

Insider: Trigg Leslie Title: Officer | Relationship: Officer

Transaction: • Type: Sell (Tax Cover) • Shares: 916 • Price: ~$4.60 • Value: $4,213.60 • Owned After: Not Disclosed

Key Insight: This is a non-discretionary sale to cover tax obligations from vested RSUs, not an active trading decision by the insider.

Market Context: The transaction value is negligible, representing ~0.005% of the company's $80M market cap.

Comprehensive Analysis

SEC Filing Analysis: Outset Medical, Inc. (OM)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: An officer at Outset Medical filed a notice to sell a small number of shares automatically to cover tax liabilities from vested Restricted Stock Units (RSUs).
  • Market Impact: This transaction is non-discretionary and immaterial in value, therefore it is expected to have a neutral market impact.

Company Information

FieldValue
CompanyOutset Medical, Inc.
Ticker SymbolOM
CIK0001484612
IndustryElectromedical & Electrotherapeutic Apparatus

Insider Information

FieldValue
NameTrigg Leslie
CIK0001304125
Title/PositionOfficer
RelationshipOfficer

Transaction Details

FieldValue
Form Type144
Transaction Date2025-11-17
Transaction CodeS
Security TypeCommon Stock
Shares Involved916
Price Per Share$4.60
Total Value$4,213.60
Shares Owned AfterNot Disclosed
Ownership TypeNot Disclosed

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$4,213.60
% of Market Cap0.0053%
Shares Transacted916
% of Shares Outstanding0.0052%
Post-Transaction OwnershipNot Disclosed
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: The proposed sale of ~$4,200 is insignificant relative to Outset Medical's $80 million market capitalization.
  • Ownership Concentration: Post-transaction ownership is not disclosed, but the size of the sale is too small to materially affect the insider's holdings.
  • Dilution Impact: Not applicable for a sale. The underlying vesting of 1,770 RSUs represents a minimal ~0.01% of shares outstanding.
  • Transaction Significance: The filing is a Form 144, a notice of proposed sale. The remarks explicitly state the sale is to cover tax withholding obligations and is not a discretionary trade. Such sales are routine and do not signal a change in the insider's outlook on the company.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The transaction is automatic, non-discretionary, and its value is immaterial compared to the company's market cap and daily trading volume. It does not reflect insider sentiment.

Volume & Sentiment

  • Expected Volume Impact: Negligible. The number of shares is too small to affect trading volume.
  • Sentiment Indicator: Neutral. The market typically disregards automated tax-related sales by insiders.

Additional Context

Special Circumstances

  • The filing remarks clearly state: "Shares sold to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale was made to satisfy tax withholding obligations through a sell to cover transaction and does not represent a discretionary trade by the reporting person."
Topics:#SECFiling#InsiderTrading#OM#OutsetMedical#Form144#StockMarket#Investing#LowSignificance

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.